Skip to Main Content

Paper Details

Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.
J Immunother Cancer
5
2023
Author NameAffiliation
Arun S SinghUniversity of California Los Angeles
Antoni RibasUniversity of California Los Angeles
Antoni RibasJonsson Comprehensive Cancer Center, University of California Los Angeles
Antoni RibasUniversity of California Los Angeles
Antoni RibasEli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California Los Angeles
Antoni RibasUniversity of California Los Angeles
Antoni RibasJonsson Comprehensive Cancer Center, University of California Los Angeles
Antoni RibasUniversity of California Los Angeles
Antoni RibasEli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California Los Angeles
  • 1 - 9

Datasets

Release 1.2